NU SKIN ENTERPRISES, INC. Finance Lease, Right-of-Use Asset, Amortization
NU SKIN ENTERPRISES, INC. (NUS) reported Finance Lease, Right-of-Use Asset, Amortization of $499.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $499.00K, a 9.44% decline year-over-year.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $512.00K, a 3.40% decline year-over-year.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $514.00K, a 1.91% decline year-over-year.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $534.00K, a 23.71% decline year-over-year.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for fiscal 2025 was $2.13M, a 21.35% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for fiscal 2024 was $2.71M, a 43.43% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for fiscal 2023 was $4.79M, a 101.81% increase from fiscal 2022.
- NU SKIN ENTERPRISES, INC. finance lease, right-of-use asset, amortization for fiscal 2022 was $2.37M, a 1.13% decline from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $499.00K 10-Q · filed 2026-08-10 | $1.01M 10-Q · filed 2026-08-10 | $1.52M derived: sum of 3 quarters · filed 2026-08-10 | $2.06M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $512.00K 10-Q · filed 2026-05-08 | $1.03M derived: sum of 2 quarters · filed 2026-05-08 | $1.56M derived: sum of 3 quarters · filed 2026-05-08 | $2.11M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.05M derived: sum of 2 quarters · filed 2026-02-13 | $1.60M derived: sum of 3 quarters · filed 2026-08-10 | $2.13M 10-K · filed 2026-02-13 |
| 2025-09-30 | $534.00K 10-Q · filed 2025-11-07 | $1.08M derived: sum of 2 quarters · filed 2026-08-10 | $1.61M 10-Q · filed 2025-11-07 | $2.14M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $551.00K 10-Q · filed 2026-08-10 | $1.08M 10-Q · filed 2026-08-10 | $1.60M derived: sum of 3 quarters · filed 2026-08-10 | $2.31M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $530.00K 10-Q · filed 2026-05-08 | $1.05M derived: sum of 2 quarters · filed 2026-05-08 | $1.75M derived: sum of 3 quarters · filed 2026-05-08 | $2.48M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $524.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.22M derived: sum of 2 quarters · filed 2026-02-13 | $1.95M derived: sum of 3 quarters · filed 2026-02-13 | $2.71M 10-K · filed 2026-02-13 |
| 2024-09-30 | $700.00K 10-Q · filed 2025-11-07 | $1.43M derived: sum of 2 quarters · filed 2025-11-07 | $2.18M 10-Q · filed 2025-11-07 | $3.13M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $725.00K 10-Q · filed 2025-08-08 | $1.48M 10-Q · filed 2025-08-08 | $2.42M derived: sum of 3 quarters · filed 2026-02-13 | $3.67M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $758.00K 10-Q · filed 2025-05-09 | $1.70M derived: sum of 2 quarters · filed 2026-02-13 | $2.94M derived: sum of 3 quarters · filed 2026-02-13 | $4.54M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $942.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.18M derived: sum of 2 quarters · filed 2026-02-13 | $3.79M derived: sum of 3 quarters · filed 2026-02-13 | $4.79M 10-K · filed 2026-02-13 |
| 2023-09-30 | $1.24M 10-Q · filed 2024-11-08 | $2.84M derived: sum of 2 quarters · filed 2024-11-08 | $3.84M 10-Q · filed 2024-11-08 | $4.58M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $1.60M 10-Q · filed 2024-08-09 | $2.60M 10-Q · filed 2024-08-09 | $3.34M derived: sum of 3 quarters · filed 2025-02-14 | $3.87M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $1.00M 10-Q · filed 2024-05-09 | $1.74M derived: sum of 2 quarters · filed 2025-02-14 | $2.27M derived: sum of 3 quarters · filed 2025-02-14 | $2.81M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $1.27M derived: sum of 2 quarters · filed 2025-02-14 | $1.81M derived: sum of 3 quarters · filed 2025-02-14 | $2.37M 10-K · filed 2025-02-14 |
| 2022-09-30 | $530.00K 10-Q · filed 2023-11-02 | $1.08M derived: sum of 2 quarters · filed 2023-11-02 | $1.63M 10-Q · filed 2023-11-02 | $2.22M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $546.00K 10-Q · filed 2023-08-02 | $1.10M 10-Q · filed 2023-08-02 | $1.69M derived: sum of 3 quarters · filed 2024-02-15 | $2.28M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $556.00K 10-Q · filed 2023-05-04 | $1.14M derived: sum of 2 quarters · filed 2024-02-15 | $1.74M derived: sum of 3 quarters · filed 2024-02-15 | $2.34M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.18M derived: sum of 2 quarters · filed 2024-02-15 | $1.79M derived: sum of 3 quarters · filed 2024-02-15 | $2.40M 10-K · filed 2024-02-15 |
| 2021-09-30 | $594.00K 10-Q · filed 2022-11-03 | $1.20M derived: sum of 2 quarters · filed 2022-11-03 | $1.81M 10-Q · filed 2022-11-03 | $2.83M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $606.00K 10-Q · filed 2022-08-05 | $1.22M 10-Q · filed 2022-08-05 | $2.24M derived: sum of 3 quarters · filed 2023-02-16 | $2.24M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $611.00K 10-Q · filed 2022-05-05 | $1.63M derived: sum of 2 quarters · filed 2023-02-16 | $1.63M derived: sum of 3 quarters · filed 2023-02-16 | $1.63M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.02M derived: sum of 2 quarters · filed 2023-02-16 | $1.02M derived: sum of 3 quarters · filed 2023-02-16 | $1.02M 10-K · filed 2023-02-16 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |